Skip to main content

Advertisement

Log in

Oxidant/antioxidant status in men with Behçet’s disease

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Behçet’s disease (BD) is a chronic, progressive disorder that affects many systems of the body including the eye. The aim of this study was to assess whether the increase in oxidative stress in the affected tissues is reflected by lipid peroxidation and to check for alterations in antioxidants and antioxidant enzyme activities in patients with BD. Erythrocyte antioxidant potential (AOP), glutathione (GSH) and GSH-dependent enzymes (glutathione peroxidase (GSH-Px), glutathione reductase (GRD) and glutathione-S-transferase (GST), catalase (CAT), Cu–Zn superoxide dismutase (Cu–Zn SOD) activities, malondialdehyde (MDA) and some trace elements (zinc, Zn; copper, Cu; manganese, Mn) levels in men with BD. Erythrocyte CAT, GSH-Px activities, MDA, GSH, AOP and serum Zn values were significantly lower in patients with BD than in the control group. However, erythrocyte Cu–Zn SOD, GRD activities, erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP) and Cu values were significantly higher in patients with BD than in the control group, but GST activity and serum Mn values were unchanged. In conclusion, our results confirm the presence of oxidative stress in patients with BD and suggest that the severity of BD may arise from impaired antioxidant mechanisms. Therapy with antioxidants may lead to the increase in the antioxidant defense system and thus improvement in clinical symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AOP:

antioxidant potential

BD:

Behçet’s disease

CAT:

catalase

CRP:

C-reactive protein

Cu–Zn SOD:

Cu–Zn superoxide dismutase

ESR:

erythrocyte sedimentation rate

DTNB:

5, 5′-dithiobis (2-nitrobenzoic acid)

GSH:

reduced glutathione

GSH-Px:

glutathione peroxidase

GRD:

glutathione reductase

H2O2 :

hydrogen peroxide

MDA:

malondialdehyde

NADPH:

reduced nicotinamide adenine dinucleotide phosphate

NADP+ :

oxidized nicotinamide adenine dinucleotide phosphate

NBT:

nitroblue tetrazolium

NO:

nitric oxide

\( {\text{O}}^{{\raise0.145em\hbox{${\scriptscriptstyle \bullet}$} - }}_{2} \) :

superoxide anion radical

\( ^{\raise0.145em\hbox{${\scriptscriptstyle \bullet}$}} {\text{OH}}^{ - } \) :

hydroxyl radicals

ONOO :

peroxynitrite

RNS:

reactive nitrogen species

ROS:

reactive oxygen species

TBA:

thiobarbituric acid

TBARS:

total thiobarbituric acid-reactive substances

References

  1. Taysi S, Kocer I, Memisogullari R, Kiziltunc A (2002) Serum oxidant/antioxidant status in serum of patients with Behçet’s disease. Ann Clin Lab Sci 32:377–382

    PubMed  CAS  Google Scholar 

  2. Behçet H (1937) Uber residivietende apththose, durch ein virus verursachte geschwura am mund, am auge und an den genitalien. Dermatol Wochenschr 105:1152–1157

    Google Scholar 

  3. Watanabe K, Ohashi Y (1984) Natural killer cells activity in patients with Behcet’s disease. Am J Ophthalmol 98:813–814

    PubMed  CAS  Google Scholar 

  4. Nussenblatt RB, Whitcup SM, Palestine AG (1996) Uveitis: fundamentals and clinical practice. Mosby, St. Louis, pp 334–353

    Google Scholar 

  5. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. New Engl J Med 341:1284–1291

    Article  PubMed  CAS  Google Scholar 

  6. El-Ageb EM, Al-Maini MH, Al-Shukaily AK, Al-Farsi Y, Richens ER (2002) Clinical features of Behçet’s disease in patients in the Sultanate of Oman; the significance of the antiphospholipid antibodies? Rheumatol Int 21:176–181

    Article  PubMed  CAS  Google Scholar 

  7. Akkus I, Kalak S, Vural H, Caglayan O, Menekse E, Can G, Durmus B (1996) Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin Chim Acta 244:221–227

    Article  PubMed  CAS  Google Scholar 

  8. Taysi S, Polat F, Gul M, Sari RA, Bakan E (2002) Lipid peroxidation, some extracellular antioxidants and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200–204

    Article  PubMed  CAS  Google Scholar 

  9. Taysi S, Gul M, Sari RA, Akcay F, Bakan N (2002) Serum oxidant/antioxidant status in serum of patients with systemic lupus erythematosus. Clin Chem Lab Med 40:684–688

    Article  PubMed  CAS  Google Scholar 

  10. Yagi K (1984) Increased lipid peroxides initiates atherogenesis. Bio Essays 1:58–60

    CAS  Google Scholar 

  11. Clemens MR, Waller HD (1987) Lipid peroxidation in erythrocytes. Chem Phys Lipids 45:251–268

    Article  PubMed  CAS  Google Scholar 

  12. Kose K, Yazici C, Cambay N, Ascioglu O, Dogan P (2002) Lipid peroxidation and erythrocyte antioxidant enzymes in patients with Behçet’s disease. Tohoku J Exp Med 197:9–16

    Article  PubMed  CAS  Google Scholar 

  13. Aydin E, Sogut S, Ozyurt H, Ozugurlu F, Akyol A (2004) Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behçet’s disease with and without ocular disease. Ophthalmic Res 36:177–182

    Article  PubMed  CAS  Google Scholar 

  14. Gul M, Kutay FZ, Temocin S, Hanninen O (2000) Cellular and clinical implications of glutathione. Indian J Exp Biol 38:625–634

    PubMed  CAS  Google Scholar 

  15. Saglam K, Serce AF, Yilmaz MI, Bulucu F, Aydin A, Akay C, Sayal A (2002) Trace elements and antioxidant enzymes in Behçet’s disease. Rheumatol Int 22:93–96

    Article  PubMed  CAS  Google Scholar 

  16. Taysi S, Gülçin I, Sari RA, Kuskay S, Bakan N (2003) Trace elements and disease activity score in patients with rheumatoid arthritis. Pain Clin 4:435–439

    Article  Google Scholar 

  17. International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080

    Google Scholar 

  18. Durak I, Karabacak HI, Buyukkocak S, Cimen MY, Kacmaz M, Omeroglu E, Ozturk HS (1998) Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C. Nephron 78:207–211

    Article  PubMed  CAS  Google Scholar 

  19. Jain SK, McVie R, Duett J, Herbst JJ (1989) Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38:1539–1543

    PubMed  CAS  Google Scholar 

  20. Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497–500

    PubMed  CAS  Google Scholar 

  21. Paglia DE, Valentina WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169

    PubMed  CAS  Google Scholar 

  22. Pinto RE, Bartley W (1969) The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates. Biochem J 112:109–115

    PubMed  CAS  Google Scholar 

  23. Sen CK, Marin E, Kretzschmar M, Hänninen O (1992) Skeletal muscle and liver glutathione homeostasis in response to training, exercise, and immobilization. J Appl Physiol 73:1265–1272

    PubMed  CAS  Google Scholar 

  24. Aebi H (1974) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic, New York, pp 673–678

    Google Scholar 

  25. Tietze (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502–522

    Article  PubMed  CAS  Google Scholar 

  26. Young IS, Woodside JV (2001) Antioxidants in health and disease. J Clin Pathol 54:176–186

    Article  PubMed  CAS  Google Scholar 

  27. Kose K, Dogan P, Ascioglu M, Erkilic K, Ascioglu O (1995) Oxidative stress and antioxidant defenses in plasma of patients with Behcet’s disease. Tohoku J Exp Med 176:239–248

    Article  PubMed  CAS  Google Scholar 

  28. Kose K, Yazici C, Assioglu O (2001) The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet’s disease. Clin Biochem 34:125–129

    Article  PubMed  CAS  Google Scholar 

  29. Dincer Y, Alademir Z, Hamuryudan V, Fresko I, Akcay T (2002) Superoxide dismutase activity and glutathione system in erythrocytes of men with Behcet’s disease. Tohoku J Exp Med 198:191–195

    Article  PubMed  CAS  Google Scholar 

  30. Memisogullari R, Taysi S, Bakan E, Capoglu I (2003) Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 21:291–296

    Article  PubMed  CAS  Google Scholar 

  31. Taysi S, Akcay F, Uslu C, Dogru Y, Gulcin I (2003) Trace elements and some extracellular antioxidant proteins levels in serum of patients with laryngeal cancer. Biol Trace Elem Res 91:11–18

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seyithan Taysi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taysi, S., Demircan, B., Akdeniz, N. et al. Oxidant/antioxidant status in men with Behçet’s disease. Clin Rheumatol 26, 418–422 (2007). https://doi.org/10.1007/s10067-006-0513-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0513-x

Keywords

Navigation